Brazil Parenteral Nutrition Market Outlook 2028
- The Brazil parenteral nutrition market was valued at US$ 157.97 Mn in 2020
- It is estimated to expand at a CAGR of 6.6% from 2021 to 2031
- The Brazil parenteral nutrition market is expected to reach the value of US$ 311.08 Mn by the end of 2031
Analysts’ Viewpoint on Brazil Parenteral Nutrition Market Scenario
Pharmaceutical compounding companies in the Brazil parenteral nutrition market are increasing the availability of life-saving therapeutic products amid the ongoing coronavirus outbreak to support vulnerable patients. Over the years, incidences of PN-related complications have reduced significantly. A key factor underpinning this positive change is the advent of technologically-advanced devices in central vascular access devices. On the other hand, indications for parenteral nutrition have grown substantially, thus expanding the canvas for players in the Brazil parenteral nutrition market to explore. The marked prevalence of metabolic disorders and end-of-life kidney diseases globally is a key driver for artificial nutrition uptake. Thus, companies should innovate in new admixture formulations to improve patient outcomes.
New Admixture Formulations Fuel Growth of Brazil Parenteral Nutrition Market
The requirement of artificial nutrition in patients with chronic diseases is an important driver that has spurred product innovations. Such trends are translating into revenue opportunities for stakeholders in the Brazil parenteral nutrition market. The use of parenteral nutrition (PN) as a life-sustaining therapy in patients with chronic short bowel syndrome and severe gastro-intestinal disorders is increasing, especially when other alternatives of artificial nutrition are not well tolerated in patients.
A growing body of studies, including randomized clinical trials, has been conducted on comparing the efficacy of parenteral nutrition with enteral nutrition. Some of the study findings suggest that parenteral nutrition therapies play a positive role in reducing mortality in critically-ill patients. Moreover, advancements in admixture formulations have resulted in making parenteral nutrition more physiologically attractive to the target patients.
Request a sample to get extensive insights into the Brazil Parenteral Nutrition Market
Government Stimulus Packages Ensure Business Continuity During COVID-19 Outbreak
Even though the COVID-19 pandemic has subsided in Brazil, the movement of goods and services is relatively slow. Hence, companies in the Brazil parenteral nutrition market are taking support of government stimulus packages to stay financially afloat amid the ongoing pandemic.
The scarcity of pharmaceutical compounds and other raw materials for intravenous devices is likely due to production stoppages and labor shortages. Nevertheless, manufacturers should increase their local production capabilities to reduce dependence on other countries for raw materials during uncertain trends in imports and exports. They should foster balanced relationship with suppliers and ecosystem partners to ensure robust and enable alternative supply chains.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Risks of Particulate Contamination and Catheter Infections Impede Market Growth
The inappropriate usage of parenteral nutrition maximizes the potential risk of adverse events such as liver dysfunction, refeeding syndrome, particulate contamination, and catheter infections to the patients undergoing the therapy. This factor is restraining growth of the Brazil parenteral nutrition market. For instance, an article published by the American Society for Nutrition in 2014 indicated that long-term parenteral nutrition therapy significantly increases the risk of metabolic complications and liver disease in patients. Thus, innovations in catheters and advancements in technologies used for vascular access in such patients hold promising potentials to improve patient quality of life. Proper training and best healthcare practices are being adopted in facilities to improve patient outcomes.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Traditional Chinese Herbal Medicine for Face-care Market
Parenteral Amino Acid Products to Attract Lucrative Business Opportunities
Based on nutrition type, pharmaceutical compounding companies in the Brazil parenteral nutrition market are experimenting in admixtures induced with vitamins, single dose amino acids, carbohydrates, parenteral lipid emulsions, trace elements, electrolytes, and minerals. The single dose amino acid segment held major share of the parenteral nutrition market in Brazil in 2020. The segment is expected to dominate the market during the forecast period. Parenteral amino acids are becoming commonplace in critical care situations such as hepatic failure, burns, premature infants, post-surgical cases, complete bowel obstruction, severe catabolism, renal disorders & prolonged coma.
Device Innovations and Malnutrition Drive Demand for Parenteral Nutrition Products
An alarming rise in the number of premature births requiring long term care is a key factor attributed to the growth of the Brazil parenteral nutrition market. Advancements in technologies used for vascular access in such patients has spurred the acceptance of parenteral nutrition in such patients. Greater focus on reducing catheter-related bloodstream infections has positively influenced the market dynamics for parenteral nutrition.
Parenteral nutrition is considered an essential treatment therapy to provide adequate nutrition support to critically ill patients. The incidence of malnutrition is increasing rapidly due to poor dietary habits in Brazil and high poverty rate in developing regions. The rise in cases of malnutrition among the geriatric population is fueling the demand for parenteral nutrition products. Moreover, protein-energy malnutrition is found to be a common state in elderly institutionalized people.
Brazil Parenteral Nutrition Market: Overview
- Parenteral nutrition is intravenous feeding of nutrition such as sugar, carbohydrates, proteins, lipids, electrolytes, and trace elements to the body
- It is considered an essential treatment therapy to provide adequate nutrition support to patients
- Parenteral nutrients are vital in maintaining high energy, hydration, and strength levels. These are often used for people with Crohn’s disease, cancer, short bowel syndrome, and ischemic bowel disease.
Surge in Cases of Malnutrition: Key Driver
- Parenteral nutrition is considered an essential treatment therapy to provide adequate nutrition support to patients. The incidence of malnutrition is increasing rapidly due to poor dietary habits in Brazil and high poverty rate in developing regions.
- Rise in cases of malnutrition among the geriatric population drives the market in the country. Protein-energy malnutrition (PEM) is a common state in elderly institutionalized people. Available data from published studies show different results on its prevalence, but values are close to 50%, varying from 10% to 85%.
- Risk of malnutrition was high among the institutionalized elderly from municipal shelter in Rio de Janeiro, Brazil. However, malnutrition was similar to the whole country, and both are usually underdiagnosed.
- Therefore, rise in prevalence of malnutrition is expected to fuel the demand for parenteral nutrition products in the country
Increase in Geriatric Population: Major Driver
- Risk of nutritional deficiency or generalized malnutrition increases with age. Hence, elderly population demonstrates high demand for parenteral administration of nutritional components such as carbohydrates, lipid emulsion, vitamins, and minerals in order to correct nutrition imbalance.
- Aging population is considered an important driver of the parenteral nutrition market. Various organizations such as the World Health Organization (WHO) and Population Reference Bureau suggested that the percentage of population aged above 50 years is increasing at a constant rate compared to the adult population.
- Therefore, the factors mentioned above are likely to accelerate the growth of the market in Brazil during the forecast period
Adults Segment to Lead Brazil Parenteral Nutrition Market
- In terms of consumer, the parenteral nutrition market in Brazil has been bifurcated into children and adults
- The adults segment dominated the market in the country in 2020. The segment is projected to register high market attractiveness index by 2031. The segment is anticipated to expand at high CAGR from 2021 to 2031.
- According to IBGE, in 1950, the national population was composed of 2.6 million seniors, representing about 4.9% of the population of Brazil. In 2020, the elderly population was 30.1 million, representing about 14.3% of the population.
Major Players
- Key players operating in the parenteral nutrition market in Brazil include
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Baxter
- Drip Hydration
- REVIV
- Eurofarma
- Nestlé Health Science
- Farmoterápica
- Each of these players has been profiled in the parenteral nutrition market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments
Brazil Parenteral Nutrition Market Snapshot
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 157.97 Mn |
|
Market Forecast Value in 2031 |
US$ 311.08 Mn |
|
Growth Rate (CAGR) |
6.6% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Brazil Parenteral Nutrition Market – Scope of Report
TMR’s report on the parenteral nutrition market in Brazil studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the parenteral nutrition market in Brazil for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the parenteral nutrition market in Brazil from 2021 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the parenteral nutrition market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the parenteral nutrition market in Brazil.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the parenteral nutrition market in Brazil. These serve as valuable tools for existing market players as well as for entities interested in participating in the parenteral nutrition market in Brazil.
The report delves into the competitive landscape of the parenteral nutrition market in Brazil. Key players operating in the parenteral nutrition market in Brazil have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the parenteral nutrition market in Brazil profiled in this report.
Key Questions Answered in Brazil Parenteral Nutrition Market Report
- What is the sales/revenue generated by parenteral nutrition suppliers/manufacturers across all regions during the forecast period?
- What are the key trends in the parenteral nutrition market in Brazil?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which region is set to expand at the fastest CAGR during the forecast period?
- Which segment will have the highest revenue in 2031 and which segment will grow at the highest CAGR during the forecast period?
Brazil Parenteral Nutrition Market – Research Objectives and Research Approach
The comprehensive report on the parenteral nutrition market in Brazil begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the parenteral nutrition market in Brazil in terms of nutrition type, consumer, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the parenteral nutrition market in Brazil.
Brazil Parenteral Nutrition Market – Segmentation
TMR’s study on the parenteral nutrition market in Brazil includes information divided into four segments: nutrition type, consumer, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the parenteral nutrition market in Brazil are discussed in detail.
| Nutrition Type |
|
| Consumer |
|
| End-user |
|
| Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Brazil Parenteral Nutrition Market
4. Market Overview
4.1. Introduction
4.1.1. Nutrition Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Brazil Parenteral Nutrition Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario
5.2. Disease Prevalence & Incidence Rate
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Brazil Parenteral Nutrition Market Analysis and Forecast, by Nutrition Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
6.3.1. Carbohydrates
6.3.2. Parenteral Lipid Emulsions
6.3.3. Single Dose Amino Acid
6.3.4. Trace Elements, Electrolytes, and Mineral
6.3.5. Vitamins
6.4. Market Attractiveness Analysis, by Nutrition Type
7. Brazil Parenteral Nutrition Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Brazil Parenteral Nutrition Market Analysis and Forecast, by Consumer
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Consumer, 2017–2031
8.3.1. Children
8.3.2. Adults
8.4. Market Attractiveness Analysis, by Consumer
9. Brazil Parenteral Nutrition Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North Brazil
9.2.2. Northeast Brazil
9.2.3. South Brazil
9.2.4. Southeast Brazil
9.2.5. Center-west Brazil
10. North Brazil Parenteral Nutrition Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
10.2.1. Carbohydrates
10.2.2. Parenteral Lipid Emulsions
10.2.3. Single Dose Amino Acid
10.2.4. Trace Elements, Electrolytes, and Mineral
10.2.5. Vitamins
10.3. Market Value & Volume Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Others
10.4. Market Value & Volume Forecast, by Consumer, 2017–2031
10.4.1. Children
10.4.2. Adults
10.5. Market Attractiveness Analysis
10.5.1. By Nutrition Type
10.5.2. By End-user
10.5.3. By Consumer
11. Northeast Brazil Parenteral Nutrition Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
11.2.1. Carbohydrates
11.2.2. Parenteral Lipid Emulsions
11.2.3. Single Dose Amino Acid
11.2.4. Trace Elements, Electrolytes, and Mineral
11.2.5. Vitamins
11.3. Market Value & Volume Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Others
11.4. Market Value & Volume Forecast, by Consumer, 2017–2031
11.4.1. Children
11.4.2. Adults
11.5. Market Attractiveness Analysis
11.5.1. By Nutrition Type
11.5.2. By End-user
11.5.3. By Consumer
12. South Brazil Parenteral Nutrition Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
12.2.1. Carbohydrates
12.2.2. Parenteral Lipid Emulsions
12.2.3. Single Dose Amino Acid
12.2.4. Trace Elements, Electrolytes, and Mineral
12.2.5. Vitamins
12.3. Market Value & Volume Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Others
12.4. Market Value & Volume Forecast, by Consumer, 2017–2031
12.4.1. Children
12.4.2. Adults
12.5. Market Attractiveness Analysis
12.5.1. By Nutrition Type
12.5.2. By End-user
12.5.3. By Consumer
13. Southeast Brazil Parenteral Nutrition Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
13.2.1. Carbohydrates
13.2.2. Parenteral Lipid Emulsions
13.2.3. Single Dose Amino Acid
13.2.4. Trace Elements, Electrolytes, and Mineral
13.2.5. Vitamins
13.3. Market Value & Volume Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Others
13.4. Market Value & Volume Forecast, by Consumer, 2017–2031
13.4.1. Children
13.4.2. Adults
13.5. Market Attractiveness Analysis
13.5.1. By Nutrition Type
13.5.2. By End-user
13.5.3. By Consumer
14. Center-west Brazil Parenteral Nutrition Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Nutrition Type, 2017–2031
14.2.1. Carbohydrates
14.2.2. Parenteral Lipid Emulsions
14.2.3. Single Dose Amino Acid
14.2.4. Trace Elements, Electrolytes, and Mineral
14.2.5. Vitamins
14.3. Market Value & Volume Forecast, by End-user, 2017–2031
14.3.1. Hospitals
14.3.2. Clinics
14.3.3. Others
14.4. Market Value & Volume Forecast, by Consumer, 2017–2031
14.4.1. Children
14.4.2. Adults
14.5. Market Attractiveness Analysis
14.5.1. By Nutrition Type
14.5.2. By End-user
14.5.3. By Consumer
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Nutrition Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. B. Braun Melsungen AG
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Product Portfolio
15.5.1.3. SWOT Analysis
15.5.1.4. Strategic Overview
15.5.2. Fresenius Kabi AG
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Product Portfolio
15.5.2.3. SWOT Analysis
15.5.2.4. Strategic Overview
15.5.3. Baxter
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Product Portfolio
15.5.3.3. SWOT Analysis
15.5.3.4. Strategic Overview
15.5.4. Drip Hydration
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Product Portfolio
15.5.4.3. SWOT Analysis
15.5.4.4. Strategic Overview
15.5.5. REVIV
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Product Portfolio
15.5.5.3. SWOT Analysis
15.5.5.4. Strategic Overview
15.5.6. Eurofarma
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Product Portfolio
15.5.6.3. SWOT Analysis
15.5.6.4. Strategic Overview
15.5.7. Nestlé Health Science
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Product Portfolio
15.5.7.3. SWOT Analysis
15.5.7.4. Strategic Overview
15.5.8. Farmoterápica
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Product Portfolio
15.5.8.3. SWOT Analysis
15.5.8.4. Strategic Overview
List of Tables
Table 01: South Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, by Nutrition Type, 2017–2031
Table 02: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2017–2031
Table 03: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2017–2031
Table 04: North Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, by Nutrition Type, 2017–2031
Table 05: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2017–2031
Table 06: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2017–2031
Table 07: Center-west Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, by Nutrition Type, 2017–2031
Table 08: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2017–2031
Table 09: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2017–2031
List of Figures
Figure 01: Brazil Parenteral Nutrition Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Brazil Parenteral Nutrition Market Value Share, by Nutrition Type, 2020
Figure 03: Brazil Parenteral Nutrition Market Value Share, by Consumer, 2020
Figure 04: Brazil Parenteral Nutrition Market Value Share, by End-user, 2020
Figure 05: Brazil Parenteral Nutrition Market Value Share, by Region, 2020
Figure 06: Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 07: Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 08: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Carbohydrates, 2017–2031
Figure 09: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Parenteral Lipid Emulsions, 2017–2031
Figure 10: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Single Dose Amino Acids, 2017–2031
Figure 11: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Trace Elements, Electrolytes, & Minerals, 2017–2031
Figure 12: Brazil Parenteral Nutrition Market Value (US$ Mn), by Vitamins, 2017–2031
Figure 13: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 14: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 15: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Children, 2017–2031
Figure 16: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Adults, 2017–2031
Figure 17: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 18: Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 19: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 20: Brazil Parenteral Nutrition Market Revenue (US$ Mn), by Clinics, 2017–2031
Figure 21: Brazil Parenteral Nutrition Market Value (US$ Mn), by Others, 2017–2031
Figure 22: Brazil Parenteral Nutrition Market Value Share Analysis, by Region, 2020 and 2031
Figure 23: Brazil Parenteral Nutrition Market Analysis, by Region
Figure 24: Southeast Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 25: Southeast Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 26: Southeast Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 27: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 28: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 29: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 30: Southeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 31: Northeast Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 32: Northeast Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 33: Northeast Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 34: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 35: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 36: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 37: Northeast Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 38: South Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 39: South Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 40: South Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 41: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 42: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 43: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 44: South Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 45: North Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 46: North Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 47: North Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 48: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 49: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 50: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 51: North Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
Figure 52: Center-west Brazil Parenteral Nutrition Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 53: Center-west Brazil Parenteral Nutrition Market Value Share Analysis, by Nutrition Type, 2020 and 2031
Figure 54: Center-west Brazil Parenteral Nutrition Market Attractiveness Analysis, by Nutrition Type, 2021–2031
Figure 55: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2020 and 2031
Figure 56: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by Consumer, 2021–2031
Figure 57: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2020 and 2031
Figure 58: Center-west Brazil Parenteral Nutrition Market Value Share and Attractiveness Analysis, by End-user, 2021–2031
